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ABSTRACT
Objective To assess the association between potential
risk factors and subsequent clinically important
abdominal aortic aneurysm events (repairs and ruptures)
in women.
DesignLargeprospectiveobservationalcohortstudywith
mean follow-up of 7.8 years.
Setting 40 clinical centres across the United States.
Participants 161808 postmenopausal women aged 50-
79 enrolled in the women’s health initiative.
Main outcome measures Association of self reported or
measured baseline variables with confirmed abdominal
aortic aneurysm events assessed with multiple logistic
regression.
Results Events occurred in 184 women and were strongly
associated with age and smoking. Ever smoking, current
smoking, and amount smoked all contributed
independent risk. Diabetes showed a negative
association (odds ratio 0.29, 95% confidence interval
0.13, 0.68), as did postmenopausal hormone therapy.
Positive associations were also seen for height,
hypertension, cholesterol lowering treatment, and
coronary and peripheral artery disease.
Conclusions Our findings confirm the strong positive
associations of clinically important abdominal aortic
aneurysm with age and smoking in women and the
negative association with diabetes previously reported in
men.
INTRODUCTION
Aorticaneurysmscausearound15000deathsayearin
the United States, and 40% of these deaths are in
women.
1Mostresultfromabdominalaorticaneurysm,
whichareseveraltimesmorecommoninmen
2-6butare
more deadly in women.
78 The aetiology of aortic
aneurysm and the reasons for these sex differences
remain unknown. Most studies of abdominal aortic
aneurysm have focused primarily on men, and little
reliable information is available for women. Previous
studies have generally included too few women with
aneurysms to generate robust multivariable models
and, perhaps as a result, have been inconsistent with
respect to several factors and unable to determine
whether the negative association with diabetes
observed in men also occurs in women.
2369-12
Abetterunderstandingofthefactorsassociatedwith
aorticaneurysmsinwomenwouldallowmoreaccurate
assessment of sex differences and might improve
diagnostic vigilance and provide insights into patho-
physiology. The women’s health initiative was a large
complex clinical investigation of strategies for long
term prevention of common diseases involving
161808 women at 40 clinical centres and comprising
a set of overlapping clinical trials and an observational
study.
1314 We assessed the associations between
potential risk factors and subsequent clinically impor-
tant abdominal aortic aneurysm events (rupture and
repair) in postmenopausal women.
METHODS
This analysis included all 161808 women enrolled in
the women’s health initiative clinical trial (68132) or
observational study (93676). Eligible women were
postmenopausal, aged 50-79 at entry, had an expected
survivalofatleastthreeyears,andcouldbeexpectedto
adhere to the protocol. Women were enrolled during
1993-8andfollowedupuntiltheendofthemainstudy
in2004-5.Thestudypopulation,recruitmentmethods,
baseline data collection, enrolment, and follow-up
procedures have been previously reported.
1314 The
protocol and consent forms were approved by the
institutional review boards of the participating institu-
tions,andwritteninformedconsentwasobtainedfrom
all participants.
Except for the prospective identification of abdom-
inalaorticaneurysmevents(describedbelow),thedata
used in this analysis were obtained at the time of
enrolment.Participantswereaskedifadoctorhadever
told them that they had each condition considered,
including a previous diagnosis of abdominal or
thoracic aortic aneurysm. There was no confirmation
of these baseline reports. Height, weight, waist
circumference, and blood pressure were measured
directly.
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pressure >140/90 or use of anti-hypertensive drugs at
entry. Coronary artery disease included history of
myocardial infarction, angina, or coronary revascular-
isation. Cerebrovascular disease included history of
stroke, transient ischaemic attack, or carotid revascu-
larisation. Peripheral artery disease included “claudi-
cation or peripheral artery disease (poor blood flow to
the legs or blocked or narrowed arteries to the legs).”
Drugs for high cholesterol included both current and
past use. Venous thromboembolism included history
of deep venous thrombosis or pulmonary embolus.
Chronic obstructive pulmonary disease included
emphysema and chronic bronchitis. Non-skin cancer
also included melanoma.
An abdominal aortic aneurysm event was recorded
when a participant wasadmitted to hospital during the
study period with an aneurysm that was symptomatic
or required intervention (such as vascular or surgical
procedure), or both, and had a diagnostic or inter-
ventional procedure that demonstrated the aneurysm.
Theseeventswereidentifiedwhenparticipantsortheir
proxies completed standardised questionnaires (every
sixmonthsforparticipantsintheclinicaltrialandevery
year for those in the observational study) that asked
about all admissions since the last update. A centrally
trained local physician reviewed relevant medical
records to ensure that the event met the criteria
described above. Because a symptomatic abdominal
aortic aneurysm nearly always represents rupture,
these events should essentially all be ruptures and
repairs (either elective or emergent).
WeperformedmultiplelogisticregressionwithSAS
version9.1.Missingresponsesweretreatedas“no”for
specific diseases, including prevalent aortic aneurysm.
We included an indicator variable (not shown) for
missing values of “dugs for high cholesterol” because
this question was not asked in the early months of the
study (nor were cholesterol concentrations measured
orwomenaskedabouthighcholesterol).Weexcluded
participants with missing responses to other variables,
including hypertension. The model was adjusted for
participation in the clinical trial and assigned treat-
ment. We used Pearson correlation coefficient to
evaluate correlations between covariates and ran
additional models to evaluate potential interactions
between strong predictors.
RESULTS
At entry into the study, 301 women reported that they
had been told by a doctor that they had aortic
aneurysm. During follow-up (mean 7.8 years, median
7.9years),184abdominalaorticaneurysmeventswere
reported, 18 in the women who had reported a
diagnosis of aortic aneurysm at entry, resulting in 467
women (0.3%) with aortic aneurysm before or during
the study. Fourteen of the 184 women who had
abdominal aortic aneurysm events died within five
daysoftheevent;all14deathswereattributedto“other
cardiovascular cause,” the category under which
deaths related to aneurysm should be coded. Table 1
shows characteristics of the women with and without
events.Ourstudypopulationhadlowerratesofcurrent
smoking and most diseases than in women in previous
screening studies of abdominal aortic aneurysm.
239
Table 2 shows multivariable odds ratios for the
various factors for abdominal aortic aneurysm events.
The ratio of events to covariates is higher than the 8:1
neededforrobustlogisticregressionmodelling.
15After
we eliminated waist circumference because of high
correlationwithweight,thehighestremainingcorrela-
tion (other than those between smoking variables) was
0.26 for height and weight. Women excluded for
missingvalueswereotherwisesimilartothoseincluded
for all characteristics examined.
Abdominal aortic aneurysm events were strongly
associatedwithageandsmokingand,asexpected,with
previous diagnosis of aortic aneurysm. There were
negative associations with diabetes and with baseline
use of postmenopausal hormone therapy. Positive
associations with abdominal aortic aneurysm events
were also seen for height, hypertension, use of
cholesterol lowering drugs, and coronary and periph-
eral artery disease.
Table 1 |Characteristicsattimeofenrolmentofwomenwithand
withoutabdominalaorticaneurysm(AAA)events.Figuresare
percentagesofwomenunlessstatedotherwise
Characteristic*
AAA event
(n=184)
No event (n=161
624)
Mean (SD) age (years) 67.2 (6.2) 63.2 (7.2)
White 86.4 82.5
Black 8.2 9.0
Mean (SD) height (cm) 162.2 (6.2) 161.8 (6.7)
Mean (SD) weight (kg) 73.0 (17.2) 73.6 (16.9)
Mean (SD) waist circumference (cm) 88.8 (13.9) 86.5 (13.8)
Ever smoked (≥100 cigarettes) 82.6 48.4
Mean (SD) pack years of smokers 44.0 (28.6) 21.0 (22.2)
Current smoker 38.0 6.9
Hypertension 62.5 38.9
Drugs for high cholesterol 27.7 13.3
Coronary artery disease 26.6 6.8
Cerebrovascular disease 9.2 3.2
Peripheral artery disease 12.0 2.0
Venous thromboembolism 3.3 3.9
Diabetes mellitus 4.3 5.9
Chronic obstructive pulmonary
disease
12.0 3.5
Non-skin cancer 10.3 9.2
Previous diagnosis of aortic
aneurysm
9.8 0.2
Postmenopausal hormone therapy:
Current 19.6 40.1
Past 18.5 16.1
Alcohol use:
Never 7.1 10.9
Past drinker 28.3 18.6
<1 drink/week 28.8 32.7
1– <7 drinks/week 20.1 25.5
≥7 drinks/week 15.2 11.6
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and diabetes (P<0.005), such that diabetes amplified
the increased risk from smoking of having an event.
When we compared current smoking with never
smoking in a model that included pack years and all
other variables, the odds ratio (95% confidence inter-
val) for abdominal aortic aneurysm events was 8.73
(5.04 to 15.12).
When we used duration of hormone therapy rather
than currentor paststatus,the odds ratio forhaving an
abdominal aortic aneurysm event for up to five years’
usewas0.69(0.46to1.04)andformorethanfiveyears’
use was 0.52 (0.34 to 0.78).
As shown in table 2, the small group of womenwho
never used alcohol were not at reduced risk of
aneurysm events. In other models, we separately
compared those reporting seven or more alcohol
drinks a week, one to fewer than seven drinks a week,
or past use with a control group of women who never
used alcohol or had less than one drink a week, and
found no significant associations of alcohol use with
aortic aneurysm events.
DISCUSSION
Inthislargecohortofpostmenopausalwomenwehave
confirmed the strong positive associations of abdom-
inal aortic aneurysm events with age and smoking and
the negative association with diabetes, previously
reported in men.
2-610
Previous screening studies that used ultrasonogra-
phy have reported factors associated with abdominal
aorticaneurysmin3000-3500womeneach,
2369butthe
numbersfoundtohaveabdominalaorticaneurysm(1-
2%) were too small to generate robust models with
more than a few independent variables.
15 Similarly, a
recent report of the Life Line screening programme
included 10012 women but detected only 74
aneurysms.
12 Previous clinical diagnosis studies from
Chicago and northern California identified 109 and
115 abdominal aortic aneurysm events in women,
respectively,
1011 though only the northern California
study provided multivariable models by sex.
11 Strong
associations with abdominal aortic aneurysm in
women were found in all these studies for age and
smoking and in some for coronary and cerebral
vascular disease, and weaker associations were seen
in most for height, hypertension, and high cholesterol.
A negative association between abdominal aortic
aneurysm and diabetes was described more than a
decade ago,
416 and, though confirmed in various
studies in men,
517 whether it occurs in women has
beenuncertain.Severalstudiesfoundmarkednegative
trends in women,
2911 but these did not reach signifi-
cance. The Life Line screening programme did not
observe a negative trend,
12 and the Chicago clinical
diagnosis study reported a significant univariable
interaction between sex and diabetes, with a positive
univariableassociationforwomenbutanegativetrend
for men.
10 In our large study we examined factors
associated with abdominal aortic aneurysm in women
and found a significant negative association with
diabetes. No adequate explanation of the mechanism
of this negative association has yet emerged,
18 but the
observation adds to the evidence for a common
pathophysiology of abdominal aortic aneurysm in
men and women and for a fundamental difference
between aneurismal and occlusive vascular disease.
19
We observed a negative association between post-
menopausal hormone therapy and aortic aneurysm,
which was significant for use at time of enrolment and
for duration of use over five years. There is some
precedent in the literature for this association: the
northern California study reported a non-significant
trend in the same direction,
11 and a recent review of
animal data found evidence for “a possible role for
estrogen in protection against abdominal aortic
aneurysm.”
8 On the other hand, 33 of the 184
aneurysm events described in our analysis have been
included in previous publications from the women’s
health initiative, and these reported hormone therapy
effects from the randomised trials that differ from the
effectsweobservedfromhormonetherapyusedbefore
enrolment. Women randomised to hormone therapy
had significantly more abdominal aortic aneurysm
events than controls in the Estrogen Alone trial (14 v 6
cases, hazard ratio 2.4)
20 and a number similar to
controls in the Estrogen plus Progesterone trial (7 v 6,
hazard ratio 1.1).
21 Possible sources of discrepancies
between baseline and randomised effects of hormone
therapy in the women’s health initiative have been
Table 2 |Multivariablemodel*offactorsassociatedwith
abdominalaorticaneurysmevent
Factor† Odds ratio (95% CI)
No of women with/without an event‡ 164/147 885
Age (per 10 years) 1.77 (1.37 to 2.29)
Black race (v white) 0.77 (0.43 to 1.38)
Other race (v white) 1.23 (0.63 to 2.39)
Height (per 10 cm) 1.50 (1.15 to 1.96)
Weight (per 10 kg) 0.96 (0.86 to 1.07)
Ever smoked (≥100 cigarettes) 1.94 (1.16 to 3.24)
Current smoker (v past smoker) 4.19 (2.93 to 6.01)
Pack years (per 5 pack years) 1.11 (1.08 to 1.14)
Hypertension (>140/90 or medication) 2.14 (1.51 to 3.03)
Drugs for high cholesterol 1.66 (1.15 to 2.39)
Coronary artery disease 2.38 (1.61 to 3.51)
Cerebrovascular disease 1.15 (0.66 to 2.00)
Peripheral artery disease 1.81 (1.05 to 3.11)
Venous thromboembolism 0.58 (0.25 to 1.34)
Diabetes mellitus 0.29 (0.13 to 0.68)
Chronic obstructive pulmonary disease 1.44 (0.88 to 2.37)
Non-skin cancer 0.94 (0.57 to 1.56)
Previous diagnosis of aortic aneurysm 9.00 (4.71 to 17.20)
Current hormone therapy (v never) 0.48 (0.31 to 0.73)
Past hormone therapy (v never) 0.76 (0.50 to 1.14)
Current alcohol use (v never) 0.73 (0.39 to 1.36)
Past alcohol use (v never) 0.95 (0.49 to 1.83)
*Model also adjusted for participation in clinical trial and assigned
treatment.
†Status at time of enrolment.
‡After exclusion of women with missing values.
RESEARCH
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ment and possible confounding by differences in
lifestyle in the baseline data.
22 Further studies will be
needed to clarify the effect of hormone therapy on
aortic aneurysm.
The small but significant association we found
between height and aortic aneurysm has been seen in
previous studies in both men and women,
459-11 even
when abdominal aortic aneurysm was defined relative
to the suprarenal aorta rather than by unadjusted
diameter,
4thoughtoourknowledgenoexplanationfor
this association has been proposed. Neither our study
northenorthernCaliforniastudy
11providesupportfor
a recent report of an association between alcohol
consumption and abdominal aortic aneurysm.
23
It remains unclear why prevalence of abdominal
aortic aneurysm differs so much by sex, even after
multivariable adjustment for known associations.
These adjustments might have been incomplete or
there might be an as yet undiscovered biological
explanation, possibly related to sex steroid hormones.
Regardless, the negative association of abdominal
aortic aneurysm with diabetes seems to be common
to both sexes.
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